These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4813955)

  • 1. Effects of glucagon on plasma lipids in different types of primary hyperlipoproteinemia.
    Aubry F; Marcel YL; Davignon J
    Metabolism; 1974 Mar; 23(3):225-38. PubMed ID: 4813955
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic effects of glucagon in endogenous hypertriglyceridemia.
    Nosadini R; Soldà G; de Biasi F; Tiengo A
    Acta Diabetol Lat; 1978; 15(5-6):251-8. PubMed ID: 219650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of exercise in patients with type IV hyperlipoproteinemia.
    Sannerstedt R; Sanbar SS; Conway J
    Am J Cardiol; 1970 Jun; 25(6):642-8. PubMed ID: 5420905
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types 3, IV, and V familial hyperlipoproteinemia.
    Glueck CJ
    Metabolism; 1971 Jul; 20(7):691-702. PubMed ID: 5090133
    [No Abstract]   [Full Text] [Related]  

  • 5. Norethindrone acetate, postheparin lipolytic activity, and plasma triglycerides in familial types I, 3, IV, and V hyperlipoproteinemia. Studies in 26 patients and 5 normal persons.
    Glueck CJ; Levy RI; Fredrickson DS
    Ann Intern Med; 1971 Sep; 75(3):345-52. PubMed ID: 5568147
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum and tissue lipid metabolism and effect of nicotinic acid in different types of hyperlipidemia.
    Carlson LA; Walldius G
    Adv Exp Med Biol; 1972; 26(0):165-78. PubMed ID: 4370366
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained effect of zinc-protamin-glucagon in hyperlipidaemic patients.
    Buch J; Buch A
    Acta Pharmacol Toxicol (Copenh); 1983 Sep; 53(3):188-92. PubMed ID: 6637508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous hypertriglyceridemia in type II hyperlipoproteinemia.
    Blankenhorn DH; Chin HP; Jensen J
    Am J Hum Genet; 1970 Sep; 22(5):493-504. PubMed ID: 5516234
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of high-carbohydrate diets on lipid and carbohydrate metabolism in the rat.
    Eaton RP; Kipnis DM
    Am J Physiol; 1969 Oct; 217(4):1160-8. PubMed ID: 5824318
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pancreatitis in idiopathic hyperlipidemias. Personal series of 40 cases].
    de Gennes JL; Turpin G; Truffert J
    Ann Med Interne (Paris); 1974 Apr; 125(4):333-46. PubMed ID: 4433096
    [No Abstract]   [Full Text] [Related]  

  • 11. Type IV hyperlipoproteinemia. A critical appraisal.
    Schonfeld G; Kudzma DJ
    Arch Intern Med; 1973 Jul; 132(1):55-62. PubMed ID: 4716427
    [No Abstract]   [Full Text] [Related]  

  • 12. Central and Peripheral Glucagon Reduces Hyperlipidemia in Rats and Hamsters.
    Patel V; Joharapurkar A; Kshirsagar S; Patel HM; Pandey D; Patel D; Shah K; Bahekar R; Shah GB; Jain MR
    Drug Res (Stuttg); 2017 Jun; 67(6):318-326. PubMed ID: 28445900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein lipase activity of huuman adipose tissue in different types of hyperlipidemia.
    Persson B
    Acta Med Scand; 1973 May; 193(5):447-56. PubMed ID: 4577684
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rapid changes in blood lipid parameters induced by glucuronyl glucosamine glycan sulfate in obese diabetic and hyperlipidemia patients].
    Ferlito S; La Spina E; Fichera C; Cultrera E; Patanè M; Ciulla P
    Arch Sci Med (Torino); 1982; 139(4):441-8. PubMed ID: 7168636
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol-induced hyperlipidemia and beta lipoproteins.
    Mendelson JH; Mello NK
    Science; 1973 Jun; 180(4093):1372-4. PubMed ID: 4709874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Triglycerides, free fatty acids and cholesterol after fat loading and heparin injection in diabetics with and without hyperlipoproteinemia as well as after clofibrate treatment].
    Singer P; Gnauck G; Honigmann G; Thoelke H; Schliack V; Läuter J
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(1):27-37. PubMed ID: 913315
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of a glucose load on lipid metabolic indices in coronary arteriosclerosis with varying types of hyperlipoproteinemia].
    Bobkova VI; Sidakova NM; Fomchenkov SI
    Kardiologiia; 1978 Mar; 18(3):66-73. PubMed ID: 642243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. II. Lipid compounds in the blood serum].
    Torbus-Lisiecka B; Wesołowska T; Wira D; Chełstowski K; Bukowska H; Gregorczyk J; Pieczul-Mróz J; Olejak B
    Przegl Lek; 1983; 40(9):677-84. PubMed ID: 6665225
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon and lipoproteins.
    Eaton RP
    Metabolism; 1976 Nov; 25(11 Suppl 1):1415-7. PubMed ID: 790087
    [No Abstract]   [Full Text] [Related]  

  • 20. [Triglyceride, free fatty acid, lipid and cholesterol levels in the serum of infants with nutrition disorders after stimulation with glucagon].
    Jabłońska-Ulbrych A; Gebala A
    Pediatr Pol; 1985; 60(11-12):780-9. PubMed ID: 3835531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.